Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00687999
Show Display Options
Rank Status Study
1 Completed NIDDM and IR in Combination Therapy for CHC
Conditions: Chronic Hepatitis C;   Insulin Resistance
Intervention: Drug: pegylated interferon alpha and ribavirin

Study has passed its completion date and status has not been verified in more than two years.